ONMD

OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry

OneMedNet's AI-Powered RWD Platform Launch Fuels Subscription Growth

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>&lt;link type=&quot;text/css&quot; rel=&quot;stylesheet&quot; href=&quot;https://www.globenewswire.com/styles/gnw_nitf.css&quot;&gt;&lt;/li...</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>OneMedNet Corporation has launched its AI-ready Real-World Data Platform, enhancing subscription services and expected recurring revenue. Early feedback indicates strong analytical capabilities, potentially boosting the company&#039;s appeal in the life sciences sector and driving predictable growth moving forward.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>OneMedNet launched its AI-ready RWD Platform powered by Palantir Foundry.</li><li>The company is converting customer evaluations into multi-year subscriptions.</li><li>Subscription contracts are expected to generate millions in recurring revenue.</li><li>Expansion of their healthcare network supports subscription value and analytical capabilities.</li><li>Positive customer feedback highlights the platform&#039;s speed and depth for real-world data.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Palantir Technologies (PLTR)</strong>: Partnership enhances OneMedNet’s platform, potentially impacting both companies positively.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>The launch fits within Corporate Developments as it marks a significant progression in OneMedNet&#039;s service offerings, likely reshaping market dynamics and investment potential in data solutions for life sciences.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Successful conversion of evaluations to subscriptions could impact revenue forecasts positively.</li><li>Expanding network of healthcare sites boosts the platform&#039;s market appeal.</li><li>Positive customer testimonials may reinforce investor confidence in growth trajectory.</li><li>Continuous improvement in analytical depth could lead to higher contract values.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Company launched its RWD Platform on February 27, 2026.</li><li>Over 2,130 healthcare sites are now part of the OneMedNet network.</li><li>The platform is integrated with Palantir Foundry for enhanced analytics.</li><li>The company aims to convert evaluations into multi-year contracts generating millions in ARR.</li><li>Customer feedback indicates improvements in speed and analytical capabilities over Fall 2025.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Consider ONMD for potential growth as multi-year subscriptions are expected to increase revenue significantly in 2026.</p>
  </section>
</section>


<article>
    <h2>OneMedNet Corporation Launches Next Phase of RWD Platform with Palantir Foundry Integration</h2>
    <p>MINNEAPOLIS, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:<a href="https://www.benzinga.com/quote/ONMD">ONMD</a>), a pioneering provider of regulatory-grade, AI-ready Real-World Data (RWD), has announced the next phase of the commercial rollout of its RWD Platform, which is powered by Palantir Foundry. This follow-up comes after the successful demonstration on November 10, 2025, that showcased live data feeds, subscription services, and AI-driven search capabilities at prominent industry tradeshows.</p>

    <section>
        <h3>Commercial Subscription Growth and Insights</h3>
        <p>The latest launch is set to accelerate the growth of subscription contracts, including multi-year agreements projected to yield millions in incremental recurring revenue. Adoption of OneMedNet's platform is seeing significant traction across life sciences and AI health innovators, underscoring a robust demand for real-world evidence (RWE) solutions.</p>

        <ul>
            <li>Over <strong>2,130 healthcare sites</strong> are part of the OneMedNet network.</li>
            <li>Increased scale and diversity lead to higher subscription value.</li>
            <li>Enhanced real-time access contributes to improved analytical depth and speed.</li>
        </ul>

        <p>Customer evaluations conducted since Fall 2025 reveal high satisfaction levels, emphasizing the platform's exceptional capabilities in integrating clinical and longitudinal datasets, accelerating cohort feasibility, and streamlining workflows.</p>
    </section>

    <section>
        <h3>Investor and Customer Benefits of the RWD Launch</h3>
        <h4>Benefits for Investors</h4>
        <p>The commercial launch of OneMedNet's platform signifies a promising advancement for its high-margin recurring revenue model. With customers transitioning to multi-year subscriptions, the company anticipates consistent growth and the generation of millions in incremental annual recurring revenue (ARR). As the network expands, larger deal sizes and deeper penetration in life sciences and AI research are expected, further fueling sustained bookings.</p>

        <h4>Benefits for Customers</h4>
        <p>Life sciences teams, health systems, and researchers stand to benefit from near real-time access to comprehensive, regulatory-grade multimodal RWD. Key benefits include:</p>
        <ul>
            <li><strong>AI-powered search</strong> for nuanced insights across clinical and imaging data.</li>
            <li>Accelerated cohort building and feasibility, reducing timelines from weeks to minutes.</li>
            <li>Enhanced tools for RWE study design and evidence generation, lowering trial risks and streamlining submissions.</li>
        </ul>
    </section>

    <section>
        <h3>Unique Features of the OneMedNet iRWD Platform</h3>
        <p>Every dataset integrated into the OneMedNet iRWD platform powered by Palantir Foundry is continuously live, allowing real-time connectivity to data sources. This unique feature ensures sustained, longitudinal access of over <strong>20 years</strong> of historical data, with projections extending up to <strong>3 years</strong> into the future. This capability cultivates richer datasets, facilitating deeper insights and ongoing evidence generation.</p>
    </section>

    <section>
        <h3>Executive Insights on Platform Performance</h3>
        <p>Aaron Green, CEO & President of OneMedNet, commented, “OneMedNet's platform is redefining how organizations access and operationalize real-world data through the expansion of our products and solutions. Customer feedback has reinforced the platform's capabilities in performance, speed, and depth of discovery. We believe this traction underlines our strategy of combining conversational AI-driven search with scalable data feeds, enhancing customer confidence and driving subscription growth.”</p>
    </section>

    <section>
        <h3>About OneMedNet Corporation</h3>
        <p>OneMedNet is at the forefront of unlocking Real-World Data (RWD) through its innovative iRWD™ platform, leveraging untapped resources from over <strong>2,130 healthcare sites</strong>. The organization harnesses diverse data types ranging from de-identified medical imaging to electronic health records, providing key insights that drive breakthroughs for drug manufacturers, medical device developers, and AI technologists. This network addresses numerous medical fields, including oncology and cardiology, offering precision insights that enhance patient care.</p>
        
        <p>In addition to healthcare, OneMedNet's AI capabilities allow for data anonymization across sectors like finance, retail, and telecom, enabling secure data sharing and testing of production system upgrades while mitigating project risks.</p>
        <p>For more information, visit <a href="https://www.onemednet.com" rel="nofollow" target="_blank">www.onemednet.com</a>.</p>
    </section>

    <section>
        <h3>Cautionary Note Regarding Forward-Looking Statements</h3>
        <p>This announcement contains forward-looking statements as defined by the Securities Acts. All statements, other than historical facts, are subject to certain risks and uncertainties, including those outlined in OneMedNet's most recent Annual Report on Form 10-K and subsequent SEC filings. OneMedNet does not undertake to update or revise any forward-looking statement, except as required by law.</p>
    </section>

    <section>
        <h3>Contact Information</h3>
        <p>Michael Wong, VP Marketing</p>
        <p>Email: <a href="mailto:michael.wong@onemednet.com">michael.wong@onemednet.com</a></p>
    </section>
</article>

OneMedNet Corporation has launched its AI-ready Real-World Data Platform, enhancing subscription services and expected recurring revenue. Early feedback indicates strong analytical capabilities, potentially boosting the company's appeal in the life sciences sector and driving predictable growth moving forward.

OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News